Literature DB >> 17526623

Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy.

M Pagkalos1, N Koutlianos, E Kouidi, E Pagkalos, K Mandroukas, A Deligiannis.   

Abstract

OBJECTIVES: Cardiac autonomic neuropathy (CAN) as a result of diabetic autonomic neuropathy is positively related to a poor prognosis in diabetic patients. The measurement of heart rate variability (HRV) is a remarkable index of cardiac autonomic dysfunction. The aim of this study was to examine the effects of long-term exercise training on HRV in type 2 diabetic patients with definite CAN.
METHODS: Seventeen type 2 diabetic patients with definite CAN (group A: 56.2 years (SD 5.8)) and 15 without CAN (group B: 55.8 years (SD 5.6)) participated in the study. All patients followed an aerobic exercise training programme three times a week for 6 months; the intensity of the session was 70% to 85% of heart rate reserve. At the beginning and end of the study all subjects underwent graded maximal exercise testing with spiroergometry for the evaluation of their aerobic capacity (VO(2)peak). Moreover, time and frequency domain indices of HRV were obtained from 24 h ambulatory continuous ECG Holter recordings.
RESULTS: At baseline, all measurements of HRV indices were significantly reduced in group A compared with group B (p<0.05). Moreover, group A reached a significantly lower VO(2)peak by 14.8% compared with group B (p<0.05). Following the exercise training programme, the SD of all normal-to-normal RR intervals in the entire recording (SDNN) was increased by 18.8% (p<0.05) and 13.8% (p<0.05), the square root of the average of sum of squares of difference between adjacent filtered RR intervals (rMSSd) was increased by 35% (p<0.05) and 15.2% (p<0.05), and the percentage of differences between adjacent filtered RR intervals which was greater than 50 ms for the entire analysis (pNN50) was increased by 400% (p<0.05) and 67.9% (p<0.05) in groups A and B, respectively. Regarding the frequency domain indices, only the high frequency power (HF) was found to be significantly increased in group A. At the end of the exercise training programme, SDNN, rMSSd and low frequency power (LF) were significantly lower (24.3% (p<0.05), 20.3% (p<0.05) and 40% (p<0.05), respectively) in group A compared with group B. Also, VO(2)peak increased by 17.8% (p<0.05) in group A and by 11% (p<0.05) in group B. Furthermore, the exercise training programme had significant effects on blood lipid and glucose levels and glycosylated haemoglobin (HbA(1c)) in both groups.
CONCLUSIONS: The results indicate that 6-month aerobic exercise training improves the cardiac autonomic nervous system function in type 2 diabetic patients. However, more favourable effects are found in type 2 diabetic patients with definite CAN.

Entities:  

Mesh:

Year:  2007        PMID: 17526623     DOI: 10.1136/bjsm.2007.035303

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  28 in total

Review 1.  Vascular Adaptation to Exercise in Humans: Role of Hemodynamic Stimuli.

Authors:  Daniel J Green; Maria T E Hopman; Jaume Padilla; M Harold Laughlin; Dick H J Thijssen
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 2.  Physical Exercise Improves Heart Rate Variability in Patients with Type 2 Diabetes: A Systematic Review.

Authors:  Santos Villafaina; Daniel Collado-Mateo; Juan Pedro Fuentes; Eugenio Merellano-Navarro; Narcis Gusi
Journal:  Curr Diab Rep       Date:  2017-09-23       Impact factor: 4.810

3.  Acute effect of photobiomodulation using light-emitting diodes (LEDs) on baroreflex sensitivity during and after constant loading exercise in patients with type 2 diabetes mellitus.

Authors:  Juliana Cristina Milan-Mattos; Cristina de Oliveira Francisco; Amanda Magdalena Ferroli-Fabrício; Vinicius Minatel; Ana Carolina Aparecida Marcondes; Alberto Porta; Thomas Beltrame; Nivaldo Antônio Parizotto; Cleber Ferraresi; Vanderlei Salvador Bagnato; Aparecida Maria Catai
Journal:  Lasers Med Sci       Date:  2019-06-15       Impact factor: 3.161

Review 4.  Cardiorespiratory Fitness and Cardiac Autonomic Function in Diabetes.

Authors:  Martin Röhling; Alexander Strom; Gidon J Bönhof; Michael Roden; Dan Ziegler
Journal:  Curr Diab Rep       Date:  2017-10-23       Impact factor: 4.810

Review 5.  Update on the treatment of type 2 diabetes mellitus.

Authors:  Juan José Marín-Peñalver; Iciar Martín-Timón; Cristina Sevillano-Collantes; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2016-09-15

Review 6.  Neurologic complications of diabetes.

Authors:  Gerald A Charnogursky; Nicholas V Emanuele; Mary Ann Emanuele
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

Review 7.  Effects of Exercise on Vascular Function, Structure, and Health in Humans.

Authors:  Daniel J Green; Kurt J Smith
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

8.  Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement.

Authors:  Sheri R Colberg; Ronald J Sigal; Bo Fernhall; Judith G Regensteiner; Bryan J Blissmer; Richard R Rubin; Lisa Chasan-Taber; Ann L Albright; Barry Braun
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

9.  Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary.

Authors:  Sheri R Colberg; Ronald J Sigal; Bo Fernhall; Judith G Regensteiner; Bryan J Blissmer; Richard R Rubin; Lisa Chasan-Taber; Ann L Albright; Barry Braun
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

10.  Plasticity of heart rate signalling and complexity with exercise training in obese individuals with and without type 2 diabetes.

Authors:  J A Kanaley; S Goulopoulou; R M Franklin; T Baynard; M E Holmstrup; R Carhart; R S Weinstock; B Fernhall
Journal:  Int J Obes (Lond)       Date:  2009-08-04       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.